Tomotaka Suzuki

8PUBLICATIONS
24CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 20, 2025
Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT.

Tomotaka Suzuki, Tomoyasu Jo, Kota Yoshifuji

|May 07, 2025
Prevalence of CCR7-Positive CD8 T Cells as a Prognostic Factor in B-Cell Maturation Antigen -Targeted Chimeric Antigen Receptor T Cell Therapy.

Yoshiaki Marumo, Masaki Ri, Toru Ebina

|Apr 23, 2025
Impact of MYD88 and/or CD79B mutations on central nervous system relapse in patients with diffuse large B-cell lymphoma.

Tomotaka Suzuki, Keiichiro Fujii, Naohiro Matsunaga

|Jan 12, 2024
Low-dose fluconazole as a useful and safe prophylactic option in patients receiving allogeneic hematopoietic stem cell transplantation.

Kentaro Hirade, Shigeru Kusumoto, Hiroya Hashimoto

|Apr 27, 2023
Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia.

Tomotaka Suzuki, Shigeru Kusumoto, Yoshiko Kamezaki

|Nov 23, 2022
Prognostic impact of the UK Myeloma Research Alliance Risk Profile in transplant-ineligible patients with multiple myeloma who received a melphalan, prednisolone, and bortezomib regimen: A supplementary analysis of JCOG1105.

Tomotaka Suzuki, Dai Maruyama, Ryunosuke Machida

Pageof 2

Frequent Collaborators

4 joint publications

Masaki Ri

3 joint publications

Shigeru Kusumoto

2 joint publications

Dai Maruyama

2 joint publications

Hiroya Hashimoto